Physician profile
Juzar Jamnagerwalla
NPI 1477969673
$7,947.37
in general payments reported to CMS, 2019-2025
33 companies · $1,683 in 2025
The $1,683 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $247 · 2021: $1,001 · 2022: $1,555 · 2023: $1,368 · 2024: $1,585 · 2025: $1,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,125 · Honoraria: $258 · Travel and Lodging: $248 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,125.35 |
| Honoraria | $257.63 |
| Travel and Lodging | $247.80 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,621.61 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Spaceoar Vue System - 10ml |
| Axonics, INC. | $1,574.41 | 2020-2024 | Axonics |
| Intuitive Surgical, INC. | $855.88 | 2022-2025 | |
| Teleflex LLC | $387.87 | 2021-2025 | Urolift |
| 180 Medical, INC. | $373.76 | 2022-2025 | Gentlecath Glide |
| Calyxo, INC. | $348.78 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $348.25 | 2019-2025 | Speedicath |
| Abbvie INC. | $328.63 | 2019-2025 | |
| Urogen Pharma, INC. | $328.29 | 2023-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $263.98 | 2021-2024 | Myrisk, Prolaris |
| Antares Pharma, INC. | $238.21 | 2019-2025 | Xyosted |
| Medtronic, INC. | $165.91 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $120.37 | 2023-2025 | Gemtesa |
| Clarus Therapeutics INC. | $111.69 | 2021 | |
| Endo Pharmaceuticals INC. | $105.44 | 2019-2023 | Aveed, Xiaflex, Edex |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $92.53 | 2022 | |
| Allergan, INC. | $89.06 | 2019-2021 | |
| Tolmar, INC. | $73.23 | 2023-2025 | Eligard, Jatenzo |
| Dendreon Pharmaceuticals LLC | $71.60 | 2019 | |
| Astellas Pharma US INC | $70.04 | 2021-2022 | |
| Caldera Medical, INC | $61.97 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.59 | 2025 | |
| Ethicon US, LLC | $38.34 | 2019 | |
| Ferring Pharmaceuticals INC. | $38.22 | 2025 | Adstiladrin |
| Neotract INC. | $37.28 | 2020 | |
| Janssen Biotech, INC. | $31.39 | 2019 | |
| Convatec INC. | $28.33 | 2023 | |
| Pfizer INC. | $19.61 | 2019 | |
| Mission Pharmacal Company | $17.47 | 2019 | |
| Amgen INC. | $16.17 | 2019 | |
| Travere Therapeutics, INC. | $15.42 | 2021 | |
| Endo USA, INC. | $14.65 | 2024 | Xiaflex |
| Blue Earth Diagnostics | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juzar Jamnagerwalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.